Relationship between liver fat content and lifestyle factors in adults with metabolic syndromeShow others and affiliations
2022 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 12, no 1, article id 17428Article in journal (Refereed) Published
Abstract [en]
The aim of this study was to investigate the associations between liver fat content (LFC), sedentary behaviour (SB), physical activity (PA), fitness, diet, body composition, and cardiometabolic risk factors in adults with metabolic syndrome. A total of 44 sedentary adults (mean age 58 [SD 7] years; 25 women) with overweight or obesity participated. LFC was assessed with magnetic resonance spectroscopy and imaging, SB and PA with hip-worn accelerometers (26 [SD 3] days), fitness by maximal bicycle ergometry, body composition by air displacement plethysmography and nutrient intake by 4-day food diaries. LFC was not independently associated with SB, PA or fitness. Adjusted for sex and age, LFC was associated with body fat%, body mass index, waist circumference, triglycerides, alanine aminotransferase, and with insulin resistance markers. There was and inverse association between LFC and daily protein intake, which persisted after further adjusment with body fat%. LFC is positively associated with body adiposity and cardiometabolic risk factors, and inversely with daily protein intake. SB, habitual PA or fitness are not independent modulators of LFC. However, as PA is an essential component of healthy lifestyle, it may contribute to liver health indirectly through its effects on body composition in adults with metabolic syndrome. © 2022, The Author(s).
Place, publisher, year, edition, pages
London: Nature Publishing Group, 2022. Vol. 12, no 1, article id 17428
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:hh:diva-48636DOI: 10.1038/s41598-022-22361-3ISI: 000870427800027PubMedID: 36261605Scopus ID: 2-s2.0-85140266577OAI: oai:DiVA.org:hh-48636DiVA, id: diva2:1713126
Funder
Academy of Finland
Note
This study was conducted within the Centre of Excellence in Cardiovascular and Metabolic Research, supported by the Academy of Finland, the University of Turku, Turku University Hospital, and Abo Akademi University. The authors thank the staff of Turku PET Centre, University of Turku, and the laboratory personnel in the Turku University Hospital Laboratory for their excellent technical assistance. The study was financially supported by Grants from Academy of Finland, Instrumentarium Science Foundation, the Finnish Cultural Foundation, the Juho Vainio Foundation, the Hospital District of Southwest Finland, the Yrjo Jahnsson Foundation, the Turku University Foundation and the Finnish Diabetes Research Foundation.
2022-11-242022-11-242022-11-24Bibliographically approved